Knocking down the expression of MACF1 and co-treatment with the chemotherapeutic drug temozolomide (TMZ) suppressed the cell proliferation of GBM cells, as compared to treatments with MACF1 siRNAs, control siRNAs, TMZ, or vehicle alone [58]. This evidence concerns the gene MACF1 and glioblastoma.